April 20, 2010

Not a week seems to go by without the West -- governments, pharmaceutical giants and the business press -- crying foul over India's handling of intellectual property. As a doctor, speaking from a medical humanitarian perspective, the case for a defense of India is clear: competition between multiple manufacturers allows for lower prices and greater access to lifesaving medicines.


View external media

Related News & Publications

Be part of MSF

Our supporters, donors and fundraisers are a vital part of the MSF movement.

Find out how you can support MSF's lifesaving work.

Learn more